Physician profile
Della Greer
NPI 1346780814
$1,672.44
in general payments reported to CMS, 2019-2025
21 companies · $367 in 2025
The $367 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $342 · 2022: $296 · 2023: $386 · 2024: $281 · 2025: $367.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,034.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,034.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $381.40 | 2023-2025 | Veozah, Myrbetriq |
| Abbvie INC. | $340.14 | 2021-2023 | |
| Daiichi Sankyo INC. | $270.10 | 2021-2025 | Injectafer |
| Exeltis, USA INC. | $89.80 | 2023-2025 | Slynd |
| Organon LLC | $77.81 | 2021-2025 | Nexplanon |
| Optumhealth Care Solutions, LLC | $69.85 | 2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Bayer Healthcare Pharmaceuticals INC. | $69.21 | 2021-2023 | |
| Pfizer INC. | $61.48 | 2023-2025 | |
| Inari Medical, INC. | $47.80 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Merck Sharp & Dohme LLC | $42.57 | 2021-2024 | Gardasil, Gardasil 9 |
| Coopersurgical, INC. | $38.19 | 2022-2023 | Paragard T 380a |
| Scynexis, INC. | $29.13 | 2022 | |
| Sumitomo Pharma America, INC. | $22.44 | 2024 | Myfembree |
| Biohaven Pharmaceutical Holding Company Ltd. | $19.34 | 2022 | |
| Supernus Pharmaceuticals, INC. | $17.98 | 2025 | Qelbree |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sage Therapeutics, LLC | $17.98 | 2025 | Zurzuvae |
| Baxter Healthcare | $17.97 | 2023 | Tisseel |
| Mayne Pharma Commercial LLC | $17.92 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $17.54 | 2023 | Exparel |
| Amgen INC. | $12.47 | 2022 | |
| Agile Therapeutics, INC. | $11.32 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Della Greer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.